Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

A randomized crossover study of prophylactic immunoglobulin (IgG) therapy was performed in patients with chronic lymphocytic leukaemia (CLL) or non-Hodgkin's lymphoma (NHL). Twelve patients with hypogammaglobulinemia or a history of recurrent infections received infusions of IgG or placebo intr...

Full description

Bibliographic Details
Main Authors:	Griffiths, H, Brennan, V, Lea, J, Bunch, C, Lee, M, Chapel, H
Format:	Journal article
Language:	English
Published:	1989

Similar Items

Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
by: Chapel, H, et al.
Published: (1991)

Immunoglobulin replacement therapy by self-infusion at home.
by: Chapel, H, et al.
Published: (1988)

Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014)

Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
by: Chapel, H, et al.
Published: (1994)

Home intravenous immunoglobulin therapy.
by: Chapel, H, et al.
Published: (1988)

Intravenous immunoglobulin therapy.
by: Chapel, H
Published: (1996)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
by: Bunch, C
Published: (1988)

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
by: Jolles, S, et al.
Published: (2016)

Self-infusion with immunoglobulin at home.
by: Chapel, H, et al.
Published: (1991)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
by: Bjorkander, J, et al.
Published: (2000)

Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.
by: Bhole, M, et al.
Published: (2008)

Predictors of infection in chronic lymphocytic leukaemia (CLL).
by: Griffiths, H, et al.
Published: (1992)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
by: Gamm, H, et al.
Published: (1988)

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia
by: Nicolò eCompagno, et al.
Published: (2014-12-01)

Hepatitis C and intravenous immunoglobulin - Concluding remarks
by: Chapel, H
Published: (1996)

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
by: Gouilleux-Gruart, V, et al.
Published: (2013)

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.
by: Brennan, V, et al.
Published: (2003)

Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
by: April C E van Gennip, et al.
Published: (2019-01-01)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Infection Outcomes in Relation to Immunoglobulin Therapy for Common Variable Immunodeficiency Disorders Over 22 Years
by: Lucas, M, et al.
Published: (2010)

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
by: Dicato, M, et al.
Published: (1991)

Intravenous immunoglobulin and hepatitis C virus: the British episode.
by: Healey, C, et al.
Published: (1996)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency.
by: Tri Dinh, et al.
Published: (2019-01-01)

Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita.
by: Tayal, U, et al.
Published: (2008)

OUTBREAK OF ACUTE HEPATITIS-C FOLLOWING INTRAVENOUS IMMUNOGLOBULIN THERAPY
by: Healey, C, et al.
Published: (1994)

Immunoglobulin replacement therapies in inborn errors of immunity: a review
by: Archan Sil, et al.
Published: (2024-02-01)

Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored
by: Qinggang Zhang, et al.
Published: (2024-03-01)

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
by: Juan Marcos Gonzalez, et al.
Published: (2022-02-01)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
by: Per Wågström, et al.
Published: (2022-01-01)

Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy
by: Sánchez-Ramón, S, et al.
Published: (2018)

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.
by: Lucas, M, et al.
Published: (2010)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
by: Suzanne Skoda-Smith, et al.
Published: (2009-12-01)

Hepatitis G virus in intravenous immunoglobulin - Reply
by: Healey, C, et al.
Published: (1996)

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
by: Chapel, H, et al.
Published: (1984)

Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies For Haematological Malignancy.
by: Silvia Sánchez-Ramón, et al.
Published: (2016-08-01)

Systemic Therapy for Low-grade Pulmonary Neuroendocrine Tumor
by: Zheng WANG, et al.
Published: (2019-01-01)

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
by: Sujoy Khan, et al.
Published: (2023-04-01)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
by: Remo Poto, et al.
Published: (2023-09-01)